Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Darba 25mcg Injection

Prescription Icon
Prescription Required

Marketer

RPG Life Sciences Ltd

Salt Composition

Darbepoetin alfa (25mcg)

Overview Darba 25mcg Injection

Erythropoietin injection (25mcg) treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. However, this medication necessitates cautious administration due to potential severe adverse reactions. Expert medical supervision is crucial; patients must meticulously adhere to their physician's instructions. Administration is exclusively under healthcare professional oversight. Common side effects comprise abdominal discomfort, hypertension, skin rashes, injection site pain, dyspnea, cough, and peripheral edema. Report symptoms of severe hypertension—including intense headache, visual disturbances, nausea, vomiting, or convulsions—immediately. Regular blood tests, monitoring electrolytes (like potassium), hemoglobin, and blood cell counts, are typically conducted. Discontinue use and seek medical counsel if experiencing shortness of breath or a skin eruption. Prior to commencing treatment, disclose any history of heart disease, hypertension, seizures, or stroke. Pregnant or breastfeeding individuals, or those planning pregnancy or breastfeeding, must consult their doctor regarding safety and suitability.

Primary Ingredients of Darba 25mcg Injection

No information provided. Please provide the text you wish me to rewrite.

Uses of Darba 25mcg Injection

Managing anemia in chronic kidney disease patients | Addressing chemotherapy-induced anemia

Major Benefits of Darba 25mcg Injection:

This medication will be administered by your physician or their qualified assistant; self-medication is strongly discouraged.

Common Side effects of Darba 25mcg Injection:

  • Abdominal pain
  • High blood pressure
  • Rash
  • Injection site pain
  • Breathlessness
  • Cough
  • Peripheral edema
  • Procedural hypotension (low blood pressure)
  • Convulsion
  • Thromboembolism

How to use Darba 25mcg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.

How Darba 25mcg Injection works:

Darba 25mcg Injection, an erythropoietin-based medication, boosts red blood cell production. This is achieved by stimulating the bone marrow's capacity to generate these essential blood components.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction between Darba 25mcg Injection and alcohol is undefined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Darba 25mcg Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Darba 25mcg Injection while breastfeeding is likely inadvisable. Preliminary research in humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Darba 25mcg Injection.

KidneyKidneySAFE IF PRESCRIBED

Darba 25mcg Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.

LiverLiverCAUTION

Individuals with hepatic impairment should use Darba 25mcg Injection cautiously. Dosage modification of Darba 25mcg Injection may be necessary. Physician consultation is advised.

What if you forget to take Darba 25mcg Injection :

Should you forget a Darba 25mcg Injection, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Darba 25mcg Injection

LabelValue
Chemical Type Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP
Action Class Erythropoietin-stimulating drug

FAQs on Darba 25mcg Injection

Expect a rise in your red blood cell count (hemoglobin levels) within 2 to 6 weeks of beginning Darba 25mcg injections. Consult your doctor with any questions or concerns.
Darba 25mcg Injection carries significant risks, including potentially fatal side effects. Expert medical supervision from a doctor experienced with Darba 25mcg Injection therapy is crucial. Adhere strictly to all prescribed instructions.
Darba 25mcg Injection may be ineffective if you have iron, folic acid, or vitamin B12 deficiencies; these should be addressed. Treatment failure may also result from bleeding, infections, inflammation, or bone marrow fibrosis. Consult your doctor for further guidance.
Darba 25mcg Injection treats anemia related to chronic kidney disease in children over one year old. Its effectiveness and side effects in children are comparable to those in adults. Consult your doctor for any concerns.
Darba 25mcg Injection can alter blood pressure. Monitor blood pressure regularly, especially at the start of treatment. Patients with hypertension should manage their blood pressure accordingly; the doctor may discontinue Darba 25mcg Injection if blood pressure remains uncontrolled.
Darba 25mcg Injection should not be used by individuals without a doctor's prescription. Furthermore, it's contraindicated for patients with uncontrolled hypertension, those with a history of pure red cell aplasia (PRCA) triggered by Darba 25mcg Injection or similar erythropoietin medications, and those with a history of serious allergic reactions to this drug.
Darba 25mcg Injection
1,953
MRP 2,261
13% off